Aminoglutethimide
Cytadren (aminoglutethimide) is a small molecule pharmaceutical. Aminoglutethimide was first approved as Cytadren on 1982-01-01. It is used to treat breast neoplasms, cushing syndrome, hormone-dependent neoplasms, and prostatic neoplasms in the USA. The pharmaceutical is active against aromatase. In addition, it is known to target cholesterol side-chain cleavage enzyme, mitochondrial.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
neoplasms | D009369 |
urogenital diseases | D000091642 |
skin and connective tissue diseases | D017437 |
endocrine system diseases | D004700 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Aminoglutethimide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CYTADREN | Novartis | N-018202 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
breast neoplasms | EFO_0003869 | D001943 | C50 |
cushing syndrome | EFO_0003099 | D003480 | E24 |
hormone-dependent neoplasms | — | D009376 | — |
prostatic neoplasms | — | D011471 | C61 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
26 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | 1 | 2 | 3 |
Fibrinolysis | D005342 | — | 1 | 1 | 1 | — | 2 | ||
Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 1 | 1 | — | 2 |
Scoliosis | D012600 | EFO_0004273 | M41 | — | — | — | 1 | 1 | 2 |
Oral hemorrhage | D006472 | — | — | — | 1 | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Spinal stenosis | D013130 | EFO_0007490 | M48.0 | — | — | — | — | 1 | 1 |
Spondylitis | D013166 | M46.9 | — | — | — | — | 1 | 1 | |
Kyphosis | D007738 | HP_0002808 | M40.20 | — | — | — | — | 1 | 1 |
Lordosis | D008141 | M40.5 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | AMINOGLUTETHIMIDE |
INN | aminoglutethimide |
Description | Aminoglutethimide is a dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position. It has a role as an antineoplastic agent, an adrenergic agent, an EC 1.14.14.14 (aromatase) inhibitor and an anticonvulsant. It is a dicarboximide, a member of piperidones and a substituted aniline. It is functionally related to a piperidine-2,6-dione. |
Classification | Small molecule |
Drug class | Aromatase inhibitor; Antiestrogen; Steroidogenesis inhibitor; Antiglucocorticoid |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCC1(c2ccc(N)cc2)CCC(=O)NC1=O |
Identifiers
PDB | — |
CAS-ID | 125-84-8 |
RxCUI | — |
ChEMBL ID | CHEMBL488 |
ChEBI ID | 2654 |
PubChem CID | 2145 |
DrugBank | DB00357 |
UNII ID | 0O54ZQ14I9 (ChemIDplus, GSRS) |
Target
Agency Approved
CYP19A1
CYP19A1
Organism
Homo sapiens
Gene name
CYP19A1
Gene synonyms
ARO1, CYAR, CYP19
NCBI Gene ID
Protein name
aromatase
Protein synonyms
CYPXIX, Cytochrome P-450AROM, Cytochrome P450 19A1, cytochrome P450, family 19, subfamily A, polypeptide 1, cytochrome P450, subfamily XIX (aromatization of androgens), Estrogen synthase, estrogen synthetase, flavoprotein-linked monooxygenase, microsomal monooxygenase
Uniprot ID
Mouse ortholog
Cyp19a1 (13075)
aromatase (P28649)
Alternate
CYP11A1
CYP11A1
Organism
Homo sapiens
Gene name
CYP11A1
Gene synonyms
CYP11A
NCBI Gene ID
Protein name
cholesterol side-chain cleavage enzyme, mitochondrial
Protein synonyms
cholesterol 20-22 desmolase, Cholesterol desmolase, cholesterol monooxygenase (side-chain cleaving), CYPXIA1, Cytochrome P450 11A1, cytochrome P450 family 11 subfamily A polypeptide 1, Cytochrome P450(scc), cytochrome P450, subfamily XIA (cholesterol side chain cleavage), steroid 20-22-lyase
Uniprot ID
Mouse ortholog
Cyp11a1 (13070)
cholesterol side-chain cleavage enzyme, mitochondrial (Q9QZ82)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,149 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
174 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more